Clinical Development Partnerships (CDP) is a joint initiative launched by Cancer Research UK, in collaboration with its development and commercialisation company Cancer ResearchTechnology Limited, to increase the number of clinical trials being undertaken for the treatment of cancer.
Cancer Research UK has a wealth of experience in early clinical development and has set an objective to double the number of clinical trials it undertakes over the next five years. CDP is central to this objective and provides a simple route for companies to progress oncology agents that would not otherwise be developed.
